NEW WEBSITE We would like to invite you to a sneak peak of our new website before it goes live. Visit the new site

Biobanks for COVID-19 research

This research area aims at developing and coordinating biobanking of COVID-19 samples (e.g. multiple sample types and longitudinal follow-up) for current and future research efforts. The ambition is sharing best practices and coordinating samples available for research. The work is carried out in collaboration with Biobank Sweden.

Furthermore, this area consists of 8 individual projects, all together funded by a total of 7,7 MSEK. Led by researchers at Uppsala University, Karolinska Institutet, Umeå University, University of Gothenburg, Lund University and Örebro University.

Coordinator: Sandra Falck, KTH Royal Institute of Technology

Scientific lead: Mia Phillipson, Uppsala University


Uppsala COVID-19 ICU Biobank
Michael Hultström, Uppsala University

Building Capacity – the Sahlgrenska Covid-19 Biobank
Magnus Gisslen, University of Gothenburg

COVID-UMU: Sample collection and understanding the transition from mild to severe COVID-19
Clas Ahlm, Umeå University

Assessment of SARS-CoV-2 specific antibodies in adults, and building a repository of samples from seroconverted asymptomatic adults
Åsa Torinsson Naluai, University of Gothenburg

The spread of SARS-CoV-2 monitored by the serum samples routinely obtained through maternal screening and blood donor screening
Martin Sundqvist, Örebro University

The COMMUNITY Study- COVID-19 Biomarker and Immunity Study
Charlotte Thålin, Karolinska Institutet/Danderyd Hospital

Establishing a biobank of clinical specimens for studying evolution of viral diversity and development of immune response, including inflammation, seroprevalence and protective antibodies, in SARS-Cov2 infection (Biobank)
Patrik Medstrand, Lund University

A biomarker-based approach to rapidly identify COVID-19 patients at high risk of severe disease and mortality at 3 emergency departments in Region Skåne
Toralph Ruge, Lund University

In addition to the above, the blood samples from infected patients that are acquired through the Hans-Gustaf Ljunggren project (KI) will be biobanked at the Stockholm Medical Biobank. The swab samples from health care and elderly care personnel that undergo qPCR analyses at Lars Engstrands facility (KI) will be stored for the regions at the KI Biobank.